CAS 866021-03-6
:1H-Pyrrolo[2,3-b]pyridine, 3-[[4-(4-chlorophényl)-1-pipérazinyl]méthyl]-,trihydrochlorure
L-745,870Trihydrochloride
CAS :Formule :C18H22Cl4N4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :436.2061L-745870 trihydrochloride
CAS :L-745870 trihydrochlorideDegré de pureté :≥95%Masse moléculaire :436.21g/molL-745870 trihydrochloride
CAS :L-745870 trihydrochloride is a highly potent and selective D4 dopamine receptor antagonist.
Formule :C18H22Cl4N4Degré de pureté :97.52%Couleur et forme :SolidMasse moléculaire :436.21L-745,870 Trihydrochloride
CAS :Produit contrôléApplications L-745,870 is a drug which acts as a dopamine receptor antagonist selective for the D4 subtype, and has antipsychotic effects in animal models, though it was not effective in human trials.
References Bristow, L., et al.: Trends in Pharma. Sci., 18, 186 (1997); Zhang, K., et al.: Neropsychopharma., 29, 1648 (2004)Formule :C18H19ClN4·3ClHCouleur et forme :NeatMasse moléculaire :436.206L-745,870 Trihydrochloride
CAS :L-745,870 is a subchronic atypical antipsychotic agent that is a potent D4 receptor agonist. Its efficacy in treating various mental disorders has been demonstrated in clinical studies with animals. L-745,870 has shown antidyskinetic activity in animal models of Parkinson's disease and dyskinesia. The molecular target for this drug is the dopamine D4 receptor. Clinical development of L-745,870 has begun in human studies.
Formule :C18H22Cl4N4Degré de pureté :Min. 95%Masse moléculaire :436.2 g/mol




